InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Puromycin | FOXP1 drives osteosarcoma development by repressing P21 and RB transcription ... | 2021 | Oncogene | Li H. et al. | DOI: 10.1038/s41388-021-01742-4 |
| 2'3'-c-di-AM(PS)2 (Rp,Rp) VacciGrade™ | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
| ADU-S100 | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
| 2'3'-cGAMP Control | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
| PMA - Phorbol myristate acetate | Ex vivo characterization of Breg cells in patients with chronic Chagas disease. | 2021 | Sci Rep. | Girard M.C. et al. | DOI: 10.1038/s41598-021-84765-x |
| C14-Tri-LAN-Gly | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
| C12-iE-DAP | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
| Zeocin® | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| QUANTI-Blue™ | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| IFN-α/β Reporter HEK 293 Cells | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| Blasticidin | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| QUANTI-Blue™ | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| QUANTI-Luc™: Luciferase Detection Reagent | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| LPS-B5 (LPS from E. coli 055:B5) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| HEK-Blue™ Selection | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| THP1-HMGB1-Lucia™ Cells | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| Pam3CSK4 | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| THP1-Blue™ ISG Cells | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
| 3'3'-cGAMP | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |